Drug Shortage Report for MYLAN-BUPRENORPHINE/NALOXONE

Last updated on 2019-09-18 History
Report ID 7392
Drug Identification Number 02408090
Brand name MYLAN-BUPRENORPHINE/NALOXONE
Common or Proper name BUPRENORPHINE/NALOXONE
Company Name MYLAN PHARMACEUTICALS ULC
Market Status CANCELLED POST MARKET
Active Ingredient(s) BUPRENORPHINE NALOXONE
Strength(s) 2MG 0.5MG
Dosage form(s) TABLET
Route of administration SUBLINGUAL
Packaging size 100BT
ATC code N07BC
ATC description DRUGS USED IN ADDICTIVE DISORDERS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2018-07-03
Actual start date 2018-06-26
Estimated end date Unknown
Actual end date 2019-09-17
Shortage status Resolved
Updated date 2019-09-18
Company comments discontinued in ID 94044. Last lot 3085355 exp 2019-05-31
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v21 2017-08-01 French Compare
v22 2017-08-15 English Compare
v23 2017-08-15 French Compare
v24 2017-09-13 English Compare
v25 2017-09-13 French Compare
v26 2017-09-21 English Compare
v27 2017-09-21 French Compare
v28 2017-09-28 English Compare
v29 2017-09-28 French Compare
v30 2017-09-29 English Compare
v31 2017-09-29 French Compare
v32 2017-10-13 English Compare
v33 2017-10-13 French Compare
v34 2017-10-13 English Compare
v35 2017-10-13 French Compare
v36 2017-10-16 English Compare
v37 2017-10-16 French Compare
v38 2017-10-19 English Compare
v39 2017-10-19 English Compare
v40 2017-10-19 French Compare

Showing 21 to 40 of 143